2026
President Trump announces a new Executive Order that directs the FDA to expedite reviews of psychedelics that have been designated as breakthrough therapy drugs: “If these turn out to be as good as people are saying, it’s going to have a tremendous impact on this… pic.twitter.com/Kut2RHohbQ – Conservative Brief (@ConservBrief) April 18, 2026
Federal continue reading …
